Use of glycerol kinase as a therapeutic target for disorders of glucose metabolism

A technology of glycerol kinase and uses, which is applied in the field of glycerol kinase as a therapeutic target for disorders of glucose metabolism, and can solve problems such as no report on the effect of glycerol kinase

Active Publication Date: 2020-08-04
SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In the prior art, there is no report on the role of glycerol kinase in type 2 diabetes and the regulation of hepatic gluconeogenesis and blood glucose homeostasis by regulating the AKT-FOXO-PEPCK / G6Pase pathway

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of glycerol kinase as a therapeutic target for disorders of glucose metabolism
  • Use of glycerol kinase as a therapeutic target for disorders of glucose metabolism
  • Use of glycerol kinase as a therapeutic target for disorders of glucose metabolism

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0107] Example 1. The expression of glycerol kinase in the liver of diabetic model mice increases, and inhibiting the expression of glycerol kinase can significantly improve the hyperglycemia and insulin sensitivity of mice

[0108] Glycerol kinase is involved in gluconeogenesis by catalyzing glycerol to 3-phosphate glycerol. Glycerol kinase is mainly expressed in the liver, followed by the kidney, with a small amount expressed in adipose tissue and skeletal muscle. The inventors found in the diabetic mouse model induced by high-fat diet that the expression of glycerol kinase (glycerol kinase, Gyk) in the liver was significantly higher than that of mice fed with control diet ( figure 1 A).

[0109] The inventors used adenovirus-mediated RNA interference to inhibit the expression of Gyk in the liver of diabetic model mice ( figure 1 B). It was found that after RNA interference Gyk expression, can significantly reduce the blood glucose and fasting blood glucose ( figure 1 C)...

Embodiment 2

[0114] Example 2. Glycerol kinase regulates gluconeogenesis and blood glucose homeostasis by regulating glycerol metabolism and AKT-FOXO1-mediated gluconeogenesis gene expression

[0115]In this example, the function and mechanism of Gyk in liver gluconeogenesis and blood glucose homeostasis were explored in normal mice.

[0116] 1. The effect of overexpression of Gyk

[0117] The present inventors utilized adenovirus-mediated overexpression of Gyk in the liver of normal mice ( figure 2 A), a significant decrease in blood glycerol concentration was found ( figure 2 B), the increase of blood glucose when the mice were free to eat ( figure 2 C), gluconeogenesis with glycerol as precursor was significantly enhanced ( figure 2 D). These results indicated that Gyk regulates gluconeogenesis by regulating glycerol metabolism at the overall level, confirming the role of Gyk in regulating gluconeogenesis with glycerol as precursor.

[0118] Pyruvate tolerance experiments showe...

Embodiment 3

[0128] Embodiment 3, drug screening

[0129] 1. Drug screening with cells expressing glycerol kinase

[0130] Primary cultured hepatocytes from mice can express glycerol kinase endogenously. The cell is used as a cell model for screening, improving or treating disorders of glucose metabolism.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to uses of glycerokinase as a glucose metabolism disorder treatment target. According to the present invention, the results show that glycerokinase can catalyze glycerol to generate 3-phosphoglycerol so as to participate in gluconeogenesis, can regulate the expressions of gluconeogenesis enzyme glucose-6-phosphatase (G6pase) and phosphoenolpyruvate carboxykinase (PEPCK) through an AKT-FOXO1 signaling pathway so as to regulate gluconeogenesis, and can provide important effects in the maintaining of the blood glucose homeostasis, such that the glycerokinase and the regulator thereof are the new target for blood glucose regulation and diabetes treatment.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, and more specifically, the invention relates to the use of glycerol kinase as a therapeutic target for disorders of glucose metabolism. Background technique [0002] Hepatic glucose metabolism (including blood glucose absorption, glycogen synthesis and breakdown, gluconeogenesis and output) plays an important role in maintaining blood glucose homeostasis. Hepatic gluconeogenesis hyperactivity is an important pathological mechanism of type 2 diabetes mellitus. Increased hepatic glucose output leads to elevated blood sugar. Correcting hyperglucose production is beneficial to control the pathogenesis of diabetes and secondary diseases. Therefore, research on inhibitors targeting glycogen production is of great significance for the control and treatment of diseases related to glucose metabolism disorders, including metabolic syndrome and type 2 diabetes. [0003] Glycerol kinase can catalyze the ph...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/00A61K48/00A61K31/7088A61P3/10A61P5/50A61P3/08C12Q1/48
CPCA61K31/7088A61K45/00C12Q1/485
Inventor 乐颖影卓鉥
Owner SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap